Loading organizations...
Tactics II Stem Cell Ventures operates as a venture capital fund, providing strategic investment and merchant banking services to the stem cell technology sector. The firm deploys capital into companies developing innovative applications from stem cell research. It supports high-potential ventures, advancing therapeutic, diagnostic, and research tools within this specialized biotechnology field.
Formed in 2010, Tactics II Stem Cell Ventures was managed by Tactics II Stem Cell General Partners, based in Northbrook, Illinois. Its inception stemmed from insight into significant opportunities within the evolving stem cell science landscape. Managing partners recognized cellular therapies' transformative potential, leading to this dedicated investment vehicle's establishment.
The fund's beneficiaries are companies developing stem cell-based solutions. Tactics II Stem Cell Ventures' vision centers on accelerating scientific discoveries into viable commercial products and clinical applications. Through targeted investments, the firm aims to bring novel stem cell technologies to market, ultimately impacting human health.
Tactics II Stem Cell Ventures has 2 tracked investments across 1 company. The latest tracked deal is $30.0M Series B in Cellular Dynamics International in April 2011.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 7, 2011 | Cellular Dynamics International | $30.0M Series B | Tactics II Stem Cell Ventures | SAM Zell, G Force, Sixth Floor Investors |
| Apr 27, 2010 | Cellular Dynamics International | $40.6M Series B | Tactics II Stem Cell Ventures | SAM Zell, Leonard Loventhal |
